PRESS-RELEASE ·Filed Jun 24, 2026
Press release · Announcement
Actionable Insight • Neutral
This is a routine operational update with no material financial or clinical catalyst. Monitor for future pipeline milestones or partnership announcements for trading signals.
Final — all horizons settled through T+60d
VRXA ▼ -36.09% at T+60d
NEUTRAL call -36.09% · α vs SPY -38.92% · entry $2.30 → $1.47
T+1d
+2.17%
call +2.17% · α +2.03%
$2.35
settled 4mo ago
T+5d
-25.00%
call -25.00% · α -26.71%
$1.73
settled 4mo ago
T+20d
-10.87%
call -10.87% · α -12.80%
$2.05
settled 3mo ago
T+60d
-36.09%
call -36.09% · α -38.92%
$1.47
settled 6w ago
Price Chart
Loading chart...
Executive Summary
VERAXA Biotech announced the expansion of its R&D facility in Heidelberg, Germany under a previously signed long-term lease. The move supports planned team additions and infrastructure build-up for its BiTAC platform pipeline, but no financial terms, revenue, or clinical milestones were disclosed.
Key Facts
- Expansion of existing R&D site in Heidelberg, Germany under a previously signed long-term lease.
- Enables accommodation for planned R&D team additions and installation of laboratory equipment.
- Supports VERAXA's BiTAC-TCE and BiTAC-ADC development programs.
- No financial terms, revenue, EPS, guidance, or clinical data disclosed.
Financial Impact
No financial figures disclosed; operational expansion only.
Risk Factors
- No near-term revenue or clinical catalysts; stock may remain range-bound.
- Forward-looking statements carry inherent risks; no guarantee of pipeline success.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3316702 |
16 reports for VRXA
100% Hit rate @ T+20 Went positive at some point 5 of 5 best @ T+60▲ +71.84%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 11d ago | 6-K | $1.11 | awaiting T+20 | — | $0.9800 (−11.71%) |
Sep 4, 2026 7w ago | 6-K | $1.76 $1.13 | ▼ −35.80% | ▼ −36.40% | $0.9800 (−44.32%) |
Sep 4, 2026 7w ago | Press Release | $1.76 $1.13 | ▼ −35.80% | ▼ −36.40% | $0.9800 (−44.32%) |
Aug 24, 2026 9w ago | 6-K | $1.78 $1.46 | ▼ −17.98% | ▼ −17.99% | $0.9800 (−44.94%) |
Aug 10, 2026 11w ago | EFFECT | $1.85 $1.60 | ▲ +13.51% | ▲ +12.60% | $0.9800 (+47.03%) |
Aug 7, 2026 11w ago | EFFECT | $1.99 $1.76 | ▲ +11.56% | ▲ +11.16% | $0.9800 (+50.75%) |
Jul 31, 2026 12w ago | F-1 | $1.83 $1.35 | ▲ +26.23% | ▲ +27.47% | $0.9800 (+46.45%) |
Jul 31, 2026 12w ago | F-1 | $1.83 $1.35 | ▲ +26.23% | ▲ +27.47% | $0.9800 (+46.45%) |
Jul 27, 2026 13w ago | 6-K | $1.98 $1.73 | ▼ −12.63% | ▼ −16.01% | $0.9800 (−50.51%) |
Jul 27, 2026 13w ago | 6-K | $2.01 $1.78 | ▼ −11.44% | ▼ −14.74% | $0.9800 (−51.24%) |
Showing 10 of 16
US Market Status
Market Closed — Opens Wed (11h 57m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers